Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 15 May 2019 21:56

The Market In Europe Accounted For Highest Revenue Share In The Global Taxifolin Market In 2017

Taxifolin Market By Type (Purity ≥95%, Purity) By Application (Food, Healthcare Products, Medicine) And Region - Global Forecast 2026


Taxifolin is a flavanonol, and is a type of flavonoid, which is highly diversified and multi-substituted subgroup. Its raw material is wood of Dahurian and Siberian larches that grow abundantly. The global Taxifolin Market is estimated to value at around US$ 0.1 Bn in 2018, and is expected to register a CAGR of 5.7%.

Global Taxifolin Market Dynamics:

Taxifolin, also known as dihydroquercetin, is a favorable natural antioxidant, which possesses anti-microbial, antibacterial, antifungal, and anti-inflammatory properties. Taxifolin is used as an additive to food products, owing to its health benefit as an antioxidant and anti-inflammatory agent, and ability to stabilize shelf life of products over 12 to 36 months. In addition, presence of even small amounts of taxifolin can prevent “oxidative stress”, and also helps to protect the body against free radicals.

However, availability of substitute to taxifolin such as quercetin is expected to hamper growth of the global target market to certain extent. Development of more cost-effective production processes could help manufacturers to reduce end-product costs, and will help to gain major revenue share in markets across the globe

Analysis By Segmentation:

The comprehensive research report comprises a complete forecast of the global taxifolin market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global taxifolin market is expected to expand at a moderate CAGR of 5.7% during the forecast period.

Global Taxifolin Market: Segmental Snapshot

The market report has been segmented on the basis of type, application, and region/country. The type segment includes purity <95% and purity ≥95%. By application segment includes food, healthcare products, and medicine. The region/country covered in the analysis are North America, Europe, China, India, Japan, Southeast Asia and Rest of the World.

By Type: The Purity ≥95% segment is expected register higher CAGR of over 5.5% as compared to other type segment. The Purity <95% segment is expected to dominate in the global market over the forecast period.

By Application: The medicine segment is expected register highest CAGR of around 5.8% in the global market

By Region/Country: The market in Europe accounted for highest revenue share in the global taxifolin market in 2017. The market in China is projected to register highest CAGR of over 6% over the forecast period.

Global Taxifolin Market: Competitive Analysis

The research report on the global taxifolin market includes profiles of some of major companies such as Linjiang Jianwei Biotech Co., Ltd., KINGHERBS Limited, JW Health Products Inc., KALENIKA Group, Ametis JSC, and Merck KGaA.

The Global Taxifolin Market: Global Industry, Size, Share, Growth, Trends, and Forecast, 2018–2027 report has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the present scenario and the growth prospects of the global taxifolin market for 2017–2027.

About Us: is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us:

Lawrence John

420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Email ID:

Tel: +1 347 826 1876 Website:

Submit a media release